Showing 1 - 10 of 2,276
-patent pharmaceuticals. We present a theoretical model with price-sensitive and loyal consumers that shows that a decrease in the reference …
Persistent link: https://www.econbiz.de/10010489291
Persistent link: https://www.econbiz.de/10011318482
Persistent link: https://www.econbiz.de/10000425502
market access to poorer groups. -- Pharmaceuticals ; Income Based Subsidies ; Parallel Imports ; Market Access …
Persistent link: https://www.econbiz.de/10003784962
Persistent link: https://www.econbiz.de/10003775010
This paper investigates the impact of population aging, driven by medical progress, upon agespecific expenditure on health care. In a model set up in discrete time, individuals at each age may catch a lethal disease which, upon receiving appropriate medical treatment, nevertheless involves a...
Persistent link: https://www.econbiz.de/10003797084
Persistent link: https://www.econbiz.de/10003699641
Persistent link: https://www.econbiz.de/10003550944
Persistent link: https://www.econbiz.de/10003966436
This paper studies interaction of pharmaceutical regulation and parallel trade in a North-South framework. An innovative Örm located in the North can sell its drug only in the North or in both countries. Governments may limit reimbursement for the drug. Reimbursement limits reduce the Örmís...
Persistent link: https://www.econbiz.de/10011290061